Use of neublastin polypeptides for treating neuropathic pain

Details for Australian Patent Application No. 2002250203 (hide)

Owner Biogen Idec MA Inc.

Inventors Sah, Dinah W. Y.

Agent Cullen & Co

Pub. Number AU-B-2002250203

PCT Pub. Number WO2002/078730

Priority 09/820,421 28.03.01 US; 60/287,554 28.03.01 US

Filing date 28 February 2002

Wipo publication date 15 October 2002

Acceptance publication date 10 August 2006

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

3 April 2003 Application Open to Public Inspection

  Published as AU-B-2002250203

28 April 2005 Change of Name(s) of Applicant(s), Section 104

  Biogen, Inc. The name of the applicant has been changed to Biogen Idec MA Inc.

10 August 2006 Application Accepted

  Published as AU-B-2002250203

7 December 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002250204-OPTIMAL ROUTE SELECTION IN A CONTENT DELIVERY NETWORK

2002250202-Preservation of metanephroi in vitro prior to transplantation